Back to Agendas
VACCINE DEVELOPMENT ACROSS REGIONS
Session Chair(s)
Françoise Rey, PharmD
Sanofi Pasteur, France
The vaccine development is a long and very complex process that could last up to 20 years before risk benefit of a new vaccine could be confirmed. It involves a combination of investigators, volunteers, health authorities, scientific experts and international organisations across all regions of the world. The recent development of vaccines against Polio disease will illustrate the development of new ways of working and interacting between Sponsors, National Health Authorities, World Health Organization and Public Private Partnership such as GAVI Alliance. The theme will explore whether it is possible to further harmonize global development across regions.
Speaker(s)
Global Regulatory Collaboration in the Framework of Polio Eradication
Fotula Fegaras, PhD
Aventis Pasteur Ltd, Canada
Clinical Research Scientist
The Role of IPV in a Post-Polio World
Oliver Rosenbauer
World Health Organization (WHO), Switzerland
Communications Officer - Global Polio Eradication Initiative
Polio Endgame: Opportunities for collaboration
Keith D Chirgwin, MD
Bill & Melinda Gates Foundation, United States
Deputy Director, Regulatory Affairs, Global Health
Registration, Regulation and Practice in China
Maozhong Li
China Food and Drug Administration, China
Deputy Director of Department, Drug and Cosmetics Registration
Have an account?